There are 206 bones in humans, and there are cells that make bones (osteoblasts) and cells that break old bones (osteoblasts), both cells work in a well-balanced manner, and work to re-create new bones in about 3 to 4 months.

In addition to aging, postmenopausal women do not secrete estrogen, which disrupts the balance of the two cells in the bone and makes the bone breaking function significant.

And there is a risk of developing osteoporosis in the cause of low bone density.

It is important to improve the balance between osteoblasts and osteoclasts.

Many people know that calcium and vitamin D are needed to control bone density loss, but that alone is not enough.

In order to improve bone quality, vitamin K is also required (included in beans, seaweed and greenish yellow vegetables).

The presence of zinc makes it easier for vitamin D to fix calcium in the bones.

In osteoporosis, zinc and selenium decrease, so it is important to replace it.

The effect of improving bone density was also confirmed in Rhodiola sacra(Salidroside).

The levels of zinc and selenium in postmenopausal blood are decreasing and are more pronounced in osteoporosis.

Zinc and selenium levels are also decreasing in rheumatoid arthritis as well.

ALP (alkaline phosphatase) is an enzyme that increases when bones are newly made, If it is less, it can not work to make new bones.

Zinc, selenium, and Rhodiola sacra (Salidroside) all seem to reduce postmenopausal bone loss and, in addition, also act to suppress bone destruction by rheumatism.

The side effects of the osteoporosis treatment which makes it easy to break bones have become a problem, but there are no reports of such side effects in zinc, selenium, or Rhodiola sacra(Salidroside). There are reports of reduced fractures①

①Clinical Cases in Mineral & Bone Metabolism 2016.13.3:181-185

It is thought to be useful for the prevention of osteoporosis, which has also increased to men.